# FDA 483 - Sterling Knight Pharmaceuticals, LLC - April 11, 2019

Source: https://www.globalkeysolutions.net/records/483/sterling-knight-pharmaceuticals-llc/12378dd4-bb70-433e-ab4f-11a6ccf554be

> FDA 483 for Sterling Knight Pharmaceuticals, LLC on April 11, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sterling Knight Pharmaceuticals, LLC
- Inspection Date: 2019-04-11
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Sterling Knight Pharmaceuticals, LLC in Ripley, MS, an own-label distributor of human drug products, revealed significant deficiencies in its quality system. The firm lacks a functional quality control unit responsible for critical tasks like complaint investigations, procedure approval, and contract manufacturer qualification. Additionally, the company failed to follow its own procedures for documenting and investigating consumer complaints.

## Related Officers

- [Jennifer L. Huntington](https://www.globalkeysolutions.net/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)

Company: https://www.globalkeysolutions.net/companies/sterling-knight-pharmaceuticals-llc/dadb3e3e-5edd-4df1-a365-2578a60cdd0c

Office: https://www.globalkeysolutions.net/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea